Skip to main content

Closed

BSX: Boston Scientific Corporation Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+17.6% / yr

Operating margin21.5%

ROIC10.8%

Financially safe

Strong

Debt / equity0.43×

Interest coverage12.4×

Current ratio1.90×

Valuation

Unrated

P/E ratio18.8×

Boston Scientific Corporation

BSXNew York Stock Exchange·USD·Closed

Boston Scientific Corporation

BSXNew York Stock Exchange·USD·Closed

$46.73

+1.59%

$46.73

+$0.73 (1.59%)

52W Range

7thpctl

Volume

0.89×avg

Mkt Cap

69.46BUSD

P/E

18.8TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.89×avg

Market Cap

69.46BUSD

P/E Ratio

18.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings